http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-0003602-B1

Outgoing Links

Predicate Object
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D207-27
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-28
classificationIPCAdditional http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D207-26
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-4015
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-40
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P25-28
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-35
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D207-27
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D207-267
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D207-263
filingDate 1979-02-09-04:00^^<http://www.w3.org/2001/XMLSchema#date>
grantDate 1984-12-12-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationDate 1984-12-12-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber EP-0003602-B1
titleOfInvention Pyrrolidine derivatives for use as therapeutically active substances and medicaments containing them
priorityDate 1978-02-10-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID8658
http://rdf.ncbi.nlm.nih.gov/pubchem/taxonomy/TAXID9521
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID230431766
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226402946
http://rdf.ncbi.nlm.nih.gov/pubchem/anatomy/ANATOMYID9521
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226447502
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458394739
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID416227409
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226399506
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID3559
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419507434
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID1115
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID3045447

Total number of triples: 30.